ACS Technologies Ltd

Financial results

• Standalone unaudited Q1 FY2026 results approved with Limited Review Report.
• Consolidated unaudited Q1 FY2026 results approved with Limited Review Report.

MOA amendment

• Amendment of MOA clause III(A) approved by board; subject to members’ Special Resolution.
• The MOA amendment narrows weapons scope and adds quantum tech R&D and software activities.

Related party transactions

• Proposed material related party transactions for FY2026-27; approval awaits members at AGM.

Trading approval for warrants-converted shares

• Trading approval from BSE for warrants-converted shares to Non-Promoters; 8,695,000 shares at Rs 31.25; listing Aug 6, 2026.

Certificate submission

• Certificate under Regulation 74(5) for quarter ended 30 June 2026 submitted via Registrar and Share Transfer Agent.

Target and acquirer

• Target: ACS Technologies Limited; Acquirer: Nexta Enterprises LLP; PACs: none other than acquirer.
• Acquirer not in promoter/promoter group; Listed on BSE Limited.

Pre-acquisition holdings

• Voting rights: 47,424 shares (0.08%); encumbrances: 0.
• Warrants/convertible: 1,25,00,000 (20.58% of capital; 12.45% diluted).
• Total pre-acquisition: 1,25,47,424 shares (20.66% capital; 12.49% diluted).

Acquisition details

• Voting rights acquired: 50,00,000 shares (7.20% capital; 4.98% diluted).
• Encumbrances: 0.
• Mode: Conversion of warrants allotted on preferential basis into equity.
• Date of acquisition/intimation: July 03, 2026.

Post-acquisition holdings and capital

• Post-acquisition: voting rights 50,47,424 shares (7.27%).
• Warrants after acquisition: 75,00,000 (10.80%); 7.47% diluted.
• Total post-acquisition: 1,25,47,424 shares (18.07% diluted).
• Equity capital before: Rs 60,74,19,480; after: Rs 69,43,69,480.
• Total diluted capital after: Rs 1,00,43,19,480 (10,04,31,948 shares).

Warrant conversion and equity allotment

• Board approved allotment of 86,95,000 equity shares on warrant conversion.
• Equity shares issued at ₹31.25 per share, including ₹21.25 premium.
• Balance consideration of ₹20.38 crore (75%) received from warrant holders.
• Allotted shares rank pari passu with existing equity shares.
• 11 non-promoter/public investors converted warrants; post-conversion holdings disclosed in annexure.
• Remaining warrants for conversion: 3,09,95,000 outstanding; exercisable within 18 months from 01 Dec 2025.
• Warrants issued on 01 Dec 2025 at ₹31.25; upfront payment ₹7.8125 per warrant; balance on exercise.

Trading Window Closure

• Trading window closed from 1 July 2026 for specified insiders.
• Closure ends 48 hours after unaudited results for quarter ending 30 June 2026.
• Board meeting date to approve results will be informed in due course.